Extensive evidence indicates that drugs and stress hormones act in the basolateral amygdala (BLA) to modulate memory consolidation. The BLA projects to the nucleus basalis magnocellularis (NBM), which sends broad cholinergic projections to the neocortex. NBM-cortex projections have been implicated in learning, memory storage, and plasticity. The current study investigated whether the cholinergic NBM-cortex projections are involved in BLA-mediated modulation of memory consolidation. Bilateral cholinergic cell lesions of the NBM were induced in rats with infusions of 192 IgG-saporin (0.1 g͞0.5 l per side). Additionally, cannulae were implanted bilaterally in the BLA. One week after surgery, the rats were trained in an inhibitory avoidance task and, immediately after training, norepinephrine (0.3 g, 1.0 g, or 3.0 g in 0.2 l) or vehicle (PBS) was infused bilaterally into the BLA. Norepinephrine infusions produced a dose-dependent enhancement of 48-h retention (0.3 g and 1.0 g doses enhanced) in nonlesioned rats but did not affect retention in NBM-lesioned rats. Choline acetyltransferase assays of frontal and occipital cortices confirmed the NBM lesions. These findings indicate that cholinergic NBM-cortex projections are required for BLA-mediated modulation of memory consolidation.acetylcholine ͉ inhibitory avoidance ͉ memory modulation ͉ rat S ystemic administration of drugs, including adrenergic agonists (1-3) and GABAergic antagonists (4-6), given immediately after training, enhances memory for several kinds of training. The basolateral amygdala (BLA) (4, 8-12) and its major efferent pathway, the stria terminalis (13-16), are critically involved in the modulation of memory consolidation induced by posttraining pharmacological treatments. In addition, considerable evidence indicates that memory modulation by systemic drugs requires -adrenergic activation in the BLA (17-21).Inhibitory avoidance (IA) tasks have been used most extensively in memory modulatory studies, as the use of a single training trial enables selective modulation of the consolidation phase of memory. Memory for IA training can be modulated by posttraining intra-BLA infusions of adrenergic (21-25), GABAergic (6,26), opioid peptidergic (19,27,28,87), glucocorticoid (21,30,31), or cholinergic drugs (32-35). As with systemic treatments, memory modulation induced by posttraining intra-BLA drug infusions acting on glucocorticoid, GABA, or opioid receptors requires concurrent -adrenergic activation in the BLA (19,21,36,37). Furthermore, it was shown recently in our laboratory that levels of amygdalar norepinephrine assessed after training predict long-term retention of IA (unpublished findings). The adrenergic-dependent memory modulation further depends upon muscarinic cholinergic activation in the BLA (31-33, 38, 39), which likely originates from the major amygdalopetal projection of the nucleus basalis magnocellularis (NBM) (37).Extensive evidence indicates that the BLA mediates the modulation of memory traces that are processed and͞or stored in othe...